Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe.

Hdl Handle:
http://hdl.handle.net/10147/302396
Title:
Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe.
Authors:
Mereckiene, J; Cotter, S; Weber, J T; Nicoll, A; D'Ancona, F; Lopalco, P L; Johansen, K; Wasley, A M; Jorgensen, P; Lévy-Bruhl, D; Giambi, C; Stefanoff, P; Dematte, L; O'Flanagan, D
Affiliation:
Health Protection Surveillance Centre, Dublin, Ireland. jolita.mereckiene@hse.ie
Citation:
Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe. 2012, 17 (4): Euro Surveill.
Publisher:
Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin
Journal:
Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin
Issue Date:
Jun-2012
URI:
http://hdl.handle.net/10147/302396
PubMed ID:
22297139
Additional Links:
http://www.ncbi.nlm.nih.gov/pubmed/22297139
Abstract:
In August 2010 the Vaccine European New Integrated Collaboration Effort (VENICE) project conducted a survey to collect information on influenza A(H1N1)pdm09 vaccination policies and vaccination coverage in the European Union (EU), Norway and Iceland. Of 29 responding countries, 26 organised national pandemic influenza vaccination and one country had recommendations for vaccination but did not have a specific programme. Of the 27 countries with vaccine recommendations, all recommended it for healthcare workers and pregnant women. Twelve countries recommended vaccine for all ages. Six and three countries had recommendations for specific age groups in children and in adults, countries for specific adult age groups. Most countries recommended vaccine for those in new risk groups identified early in the pandemic such as morbid obese and people with neurologic diseases. Two thirds of countries started their vaccination campaigns within a four week period after week 40/2009. The reported vaccination coverage varied between countries from 0.4% to 59% for the entire population (22 countries); 3% to 68% for healthcare workers (13 countries); 0% to 58% for pregnant women (12 countries); 0.2% to 74% for children (12 countries). Most countries identified similar target groups for pandemic vaccine, but substantial variability in vaccination coverage was seen. The recommendations were in accordance with policy advice from the EU Health Security Committee and the World Health Organization.
Item Type:
Article
Language:
en
Description:
In August 2010 the Vaccine European New Integrated Collaboration Effort (VENICE) project conducted a survey to collect information on influenza A(H1N1)pdm09 vaccination policies and vaccination coverage in the European Union (EU), Norway and Iceland. Of 29 responding countries, 26 organised national pandemic influenza vaccination and one country had recommendations for vaccination but did not have a specific programme. Of the 27 countries with vaccine recommendations, all recommended it for healthcare workers and pregnant women. Twelve countries recommended vaccine for all ages. Six and three countries had recommendations for specific age groups in children and in adults, countries for specific adult age groups. Most countries recommended vaccine for those in new risk groups identified early in the pandemic such as morbid obese and people with neurologic diseases. Two thirds of countries started their vaccination campaigns within a four week period after week 40/2009. The reported vaccination coverage varied between countries from 0.4% to 59% for the entire population (22 countries); 3% to 68% for healthcare workers (13 countries); 0% to 58% for pregnant women (12 countries); 0.2% to 74% for children (12 countries). Most countries identified similar target groups for pandemic vaccine, but substantial variability in vaccination coverage was seen. The recommendations were in accordance with policy advice from the EU Health Security Committee and the World Health Organization.
Keywords:
VACCINES; INFLUENZA
Local subject classification:
H1N1
MeSH:
Europe; Health Policy; Health Surveys; Humans; Iceland; Influenza A Virus, H1N1 Subtype; Influenza, Human; Norway; Pandemics; Universal Coverage; Vaccination
ISSN:
1560-7917

Full metadata record

DC FieldValue Language
dc.contributor.authorMereckiene, Jen_GB
dc.contributor.authorCotter, Sen_GB
dc.contributor.authorWeber, J Ten_GB
dc.contributor.authorNicoll, Aen_GB
dc.contributor.authorD'Ancona, Fen_GB
dc.contributor.authorLopalco, P Len_GB
dc.contributor.authorJohansen, Ken_GB
dc.contributor.authorWasley, A Men_GB
dc.contributor.authorJorgensen, Pen_GB
dc.contributor.authorLévy-Bruhl, Den_GB
dc.contributor.authorGiambi, Cen_GB
dc.contributor.authorStefanoff, Pen_GB
dc.contributor.authorDematte, Len_GB
dc.contributor.authorO'Flanagan, Den_GB
dc.date.accessioned2013-09-27T10:58:55Z-
dc.date.available2013-09-27T10:58:55Z-
dc.date.issued2012-06-
dc.identifier.citationInfluenza A(H1N1)pdm09 vaccination policies and coverage in Europe. 2012, 17 (4): Euro Surveill.en_GB
dc.identifier.issn1560-7917-
dc.identifier.pmid22297139-
dc.identifier.urihttp://hdl.handle.net/10147/302396-
dc.descriptionIn August 2010 the Vaccine European New Integrated Collaboration Effort (VENICE) project conducted a survey to collect information on influenza A(H1N1)pdm09 vaccination policies and vaccination coverage in the European Union (EU), Norway and Iceland. Of 29 responding countries, 26 organised national pandemic influenza vaccination and one country had recommendations for vaccination but did not have a specific programme. Of the 27 countries with vaccine recommendations, all recommended it for healthcare workers and pregnant women. Twelve countries recommended vaccine for all ages. Six and three countries had recommendations for specific age groups in children and in adults, countries for specific adult age groups. Most countries recommended vaccine for those in new risk groups identified early in the pandemic such as morbid obese and people with neurologic diseases. Two thirds of countries started their vaccination campaigns within a four week period after week 40/2009. The reported vaccination coverage varied between countries from 0.4% to 59% for the entire population (22 countries); 3% to 68% for healthcare workers (13 countries); 0% to 58% for pregnant women (12 countries); 0.2% to 74% for children (12 countries). Most countries identified similar target groups for pandemic vaccine, but substantial variability in vaccination coverage was seen. The recommendations were in accordance with policy advice from the EU Health Security Committee and the World Health Organization.en_GB
dc.description.abstractIn August 2010 the Vaccine European New Integrated Collaboration Effort (VENICE) project conducted a survey to collect information on influenza A(H1N1)pdm09 vaccination policies and vaccination coverage in the European Union (EU), Norway and Iceland. Of 29 responding countries, 26 organised national pandemic influenza vaccination and one country had recommendations for vaccination but did not have a specific programme. Of the 27 countries with vaccine recommendations, all recommended it for healthcare workers and pregnant women. Twelve countries recommended vaccine for all ages. Six and three countries had recommendations for specific age groups in children and in adults, countries for specific adult age groups. Most countries recommended vaccine for those in new risk groups identified early in the pandemic such as morbid obese and people with neurologic diseases. Two thirds of countries started their vaccination campaigns within a four week period after week 40/2009. The reported vaccination coverage varied between countries from 0.4% to 59% for the entire population (22 countries); 3% to 68% for healthcare workers (13 countries); 0% to 58% for pregnant women (12 countries); 0.2% to 74% for children (12 countries). Most countries identified similar target groups for pandemic vaccine, but substantial variability in vaccination coverage was seen. The recommendations were in accordance with policy advice from the EU Health Security Committee and the World Health Organization.-
dc.language.isoenen
dc.publisherEuro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletinen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/22297139en_GB
dc.rightsArchived with thanks to Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletinen_GB
dc.subjectVACCINESen_GB
dc.subjectINFLUENZAen_GB
dc.subject.meshEurope-
dc.subject.meshHealth Policy-
dc.subject.meshHealth Surveys-
dc.subject.meshHumans-
dc.subject.meshIceland-
dc.subject.meshInfluenza A Virus, H1N1 Subtype-
dc.subject.meshInfluenza, Human-
dc.subject.meshNorway-
dc.subject.meshPandemics-
dc.subject.meshUniversal Coverage-
dc.subject.meshVaccination-
dc.subject.otherH1N1en_GB
dc.titleInfluenza A(H1N1)pdm09 vaccination policies and coverage in Europe.en_GB
dc.typeArticleen
dc.contributor.departmentHealth Protection Surveillance Centre, Dublin, Ireland. jolita.mereckiene@hse.ieen_GB
dc.identifier.journalEuro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletinen_GB

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.